STK11 and neoplasm: We report that in HNC, STK11 is downregulated regardless of tumor stage or HPV presence (6.8% of total tumors), although mir-100-3p shows marginal expression in the TCGA database; we found that the reduction in expression levels of STK11 could be explained in part by the negative regulation exerted by miR-100-3p.